These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28927987)

  • 1. Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.
    Di L; Breen C; Chambers R; Eckley ST; Fricke R; Ghosh A; Harradine P; Kalvass JC; Ho S; Lee CA; Marathe P; Perkins EJ; Qian M; Tse S; Yan Z; Zamek-Gliszczynski MJ
    J Pharm Sci; 2017 Dec; 106(12):3442-3452. PubMed ID: 28927987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.
    Ryu S; Tess D; Di L
    AAPS J; 2022 Dec; 25(1):7. PubMed ID: 36471200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the importance of plasma protein binding in drug discovery and development.
    Di L
    Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interactions related to altered absorption and plasma protein binding: theoretical and regulatory considerations, and an industry perspective.
    Hochman J; Tang C; Prueksaritanont T
    J Pharm Sci; 2015 Mar; 104(3):916-29. PubMed ID: 25557998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
    Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
    J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pH dependency of the binding of drugs to plasma proteins in man.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 2005 Feb; 27(1):71-85. PubMed ID: 15665750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations.
    Gertz M; Kilford PJ; Houston JB; Galetin A
    Drug Metab Dispos; 2008 Mar; 36(3):535-42. PubMed ID: 18096674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.